That is certainly a valid point. Plus, the additional $5Million adds about 9 months of operating funds, per Dr. Diwan's statement. Previous burn rate was around/under $5million annually. So in the statement Dr. Diwan may be implying some ramp up in activity level, which, if true, would be great.
Thats also my understanding. Basically, they seem to be paying $10/share. Is that correct? That's quite a premium so they must be very confident in the future of NNVC. If so, what does it mean for the current share price? Can't wait for the open to see the market reaction.
I'm just a bit puzzled by the nearly 1/2 million in "placement agent fees and other offering expenses". Anyone can elaborate on what these expenses can be? Maybe I should become a placement agent...
I also like the "This financing positions us for meeting the listing standards of major exchanges,...”
"Seaside has financed several leading-edge bio-pharma companies, including Cytori Therapeutics, Inc., Generex Biotechnology Corporation, and NovaDel Pharma, Inc. among others We should research how these companies fared....